These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6322362)

  • 21. Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.
    Shubitz LF; Galgiani JN; Tian ZQ; Zhong Z; Timmermans P; Katz L
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3467-9. PubMed ID: 17005834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.
    Allendoerfer R; Yates RR; Marquis AJ; Loebenberg D; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1992 Jan; 36(1):217-9. PubMed ID: 1590692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
    Thompson GR; Lewis JS; Nix DE; Patterson TF
    Med Mycol; 2019 Feb; 57(Supplement_1):S76-S84. PubMed ID: 30690601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. R34000, a dioxolane imidazole in the therapy for experimental coccidioidomycosis. Comparison with miconazole and econazole.
    Levine HB
    Chest; 1976 Dec; 70(6):755-9. PubMed ID: 1001052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azole therapy of clinical and experimental coccidioidomycosis.
    Stevens DA; Clemons KV
    Ann N Y Acad Sci; 2007 Sep; 1111():442-54. PubMed ID: 17344535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral antifungal therapy. Current status of ketoconazole.
    Varkey B
    Postgrad Med; 1983 Jan; 73(1):52-3. PubMed ID: 6294644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.
    Fierer J; Kirkland T; Finley F
    Antimicrob Agents Chemother; 1990 Jan; 34(1):13-6. PubMed ID: 2327748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antifungal action of Bay b 5097 in experimental coccidioidomycosis in mice].
    Vanbreuseghem R; De Vroey C; Takashio M; Swinne-Desgain D
    Mykosen; 1975 Jan; 18(1):25-8. PubMed ID: 1117888
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis.
    Graybill JR; Kaster SR; Drutz DJ
    Antimicrob Agents Chemother; 1983 Dec; 24(6):829-34. PubMed ID: 6318660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of coccidioidomycosis with ketoconazole: an evaluation utilizing a new scoring system.
    Catanzaro A; Friedman PJ; Schillaci R; Einstein H; Kirkland TN; Levine HB; Ross JB
    Am J Med; 1983 Jan; 74(1B):64-9. PubMed ID: 6295154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketoconazole for treatment of chronic pulmonary coccidioidomycosis.
    Ross JB; Levine B; Catanzaro A; Einstein H; Schillaci R; Friedman PJ
    Ann Intern Med; 1982 Apr; 96(4):440-3. PubMed ID: 6279005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
    Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1997 Jan; 41(1):200-3. PubMed ID: 8980782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.
    Heel RC; Brogden RN; Carmine A; Morley PA; Speight TM; Avery GS
    Drugs; 1982; 23(1-2):1-36. PubMed ID: 6276122
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic evaluation of ketoconazole in patients with coccidioidomycosis.
    Welsh O; González JG; Diaz M; Madero D; González J
    Rev Infect Dis; 1980; 2(4):651-5. PubMed ID: 6255546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketoconazole in the treatment of coccidioidomycosis.
    Galgiani JN
    Drugs; 1983 Oct; 26(4):355-63. PubMed ID: 6313321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
    Clemons KV; Homola ME; Stevens DA
    Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of coccidioidomycosis osteomyelitis with itraconazole in a horse. A brief report.
    Foley JP; Legendre AM
    J Vet Intern Med; 1992; 6(6):333-4. PubMed ID: 1336557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
    Shadomy S; Espinel-Ingroff A; Kerkering TM
    Sabouraudia; 1984; 22(1):7-15. PubMed ID: 6322364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139.
    Fromtling RA; Yu HP; Shadomy S
    Sabouraudia; 1983 Sep; 21(3):179-84. PubMed ID: 6314564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
    Tucker RM; Hanson LH; Brummer E; Stevens DA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):573-5. PubMed ID: 2729949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.